Tech : 2288 – Profitable, Very Reputable Fluorescence Pharmaceutical Research Instrument Sales and Service Company in South Atlantic, USA
OPPORTUNITY AND HIGHLIGHTS
This is a unique opportunity of a niche business focused on pharmaceutical research market. The Company is currently experiencing rapid growth and good profits. The Company sells and services Fluorescence-based research instruments. The Company has been operational for past 10 years and the customers admire the Company for its passion, honesty, integrity and innovations that it has brought into the marketplace. The Company offer international client base, growing sales, and excellent growth opportunity. It has three patents on its product innovations.
The founder of the company has deep instrument and service experience and he innovated on an existing instrument and made it better. The Company holds three US Patents for the innovations that to this fluorescence instrument.
The Company currently sells and services three types of related instruments – refurbished fluorescent equipment of a original manufacturer, refurbished equipment that with improvements that it brought it and a newer generation of refurbished equipment. that it innovated on. The opportunity also includes its sister company, that provides consumables that its customers need, and has excellent vendor relationships to supply these.
This opportunity is ideal for those in the sale and service of optical research instruments and who want to expand their product and service capabilities.
The Company has no direct competitors in this field where it supplies these specialty refurbished equipment with significant improvements, at a price that is cheaper than the original manufacturer’s. Clients also appreciate its outstanding service, and its honesty, integrity and competence.
- No competition for the product it sells
- Excellent Reputation and worldwide customer base
- Two complementary business – Equipment sales and Services, and sales of parts and consumables
- Growing rapidly with the growth seen in US economy of late
- An ideal addition to existing business which sales instrument and services to pharma / research markets
- Good Vertical and Horizontal Growth opportunities by expanding service geographically and taking on sales and service of more instruments
- Three issued patents
Gross Revenue: $1.16 million (2015 projected); EBITDA: $461K (2015 projected); inventory: $1.1 million; 3 patents
Contact : Tech # 2288